0001737287-23-000091 Sample Contracts

August 11, 2023 Earl Douglas Re: Employment Letter of Agreement (“Agreement”) Dear Earl,
Restricted Stock Unit Agreement • November 2nd, 2023 • Allogene Therapeutics, Inc. • Biological products, (no disgnostic substances) • California

Allogene Therapeutics, Inc. (“Allogene” or the “Company”) is pleased to offer you employment on the following terms and conditions.

AutoNDA by SimpleDocs
ALLOGENE THERAPEUTICS, INC. Shares of Common Stock ($0.001 par value) AMENDMENT NO. 2 TO THE SALES AGREEMENT
Allogene Therapeutics, Inc. • November 2nd, 2023 • Biological products, (no disgnostic substances)

Reference is made to the Sales Agreement, dated November 5, 2019, as amended by Amendment No.1 to the Sales Agreement (the “Amendment No. 1”), dated November 2, 2022 (as amended, the “Agreement”) by and between Allogene Therapeutics, Inc., a Delaware corporation (the “Company”), and Cowen and Company, LLC (the “Agent”). The Company and the Agent (collectively, the “Parties”) wish to amend the Agreement, pursuant to Section 15 of the Agreement, to remove the specified aggregate dollar amount of Placement Shares that may be issued and sold from time to time under the Agreement (this “Amendment”). The Parties therefore hereby agree as follows:

October 12, 2023 Geoffrey Parker Re: Employment Letter of Agreement (“Agreement”) Dear Geoff,
Invention Assignment Agreement • November 2nd, 2023 • Allogene Therapeutics, Inc. • Biological products, (no disgnostic substances) • California

Allogene Therapeutics, Inc. (“Allogene” or the “Company”) is pleased to offer you employment on the following terms and conditions.

ASSET CONTRIBUTION AGREEMENT BY AND BETWEEN PFIZER INC. AND ALLOGENE THERAPEUTICS, INC. Dated as of April 2, 2018
Asset Contribution Agreement • November 2nd, 2023 • Allogene Therapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware

This Asset Contribution Agreement (this “Agreement”) is entered into as of April 2, 2018 (the “Effective Date”), by and between Pfizer Inc., a Delaware corporation (“Pfizer”), and Allogene Therapeutics, Inc., a Delaware corporation (“NewCo”).

Time is Money Join Law Insider Premium to draft better contracts faster.